Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions

AneurysmStrokeVasculitisTumor Necrosis Factor-alpha

Interventions

DRUG

Infliximab

Please see protocol for details.

Trial Locations (1)

RECRUITING

UCSF Medical Center, San Francisco

All Listed Sponsors

lead

University of California, San Francisco

OTHER